^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    milciclib (TZLS-201)

    i
    Associations
    News
    Trials
    Company:
    Nerviano Medical Sciences, Tiziana Life Sci
    Drug class:
    TrkA receptor antagonist, pan-CDK inhibitor
    Related drugs:
    Associations
    News
    Trials